給 醫 護 專 業 人 員 的 信
Tick and flea control agent Bravecto continues to be acceptably safe to use. New adverse reaction to be included in package leaflet (Letter to Healthcare Professionals) (English Only)
附件:
Tick and flea control agent Bravecto continues to be acceptably safe to use. New adverse reaction to be included in package leaflet
Related Information:
歐洲聯盟:控制蜱及蚤的藥物Bravecto使用的安全性繼續可以接受。包裝說明書應包括新的不良反應。
上載於 2017-08-18